Form 4 Filing for BioNTech SE

This filing details a transaction by Poetting Sierk, Chief Operating Officer of BioNTech SE, on April 22, 2026. Mr. Sierk disposed of 50,000 ordinary shares, with a price per share of 110.5592. Following this transaction, Mr. Sierk now beneficially owns 399,387 ordinary shares. The shares are held indirectly through Tofino GmbH, of which Mr. Sierk is the sole shareholder. The filing is made on Form 4, indicating a change in beneficial ownership.